Exploring the heterogeneity in community pharmacist-led medication review studies – A systematic review

Background: Findings on the effectiveness of medication reviews led by community pharmacists (CPs) are often inconclusive. It has been hypothesized that studies are not sufficiently standardized, and thus, it is difficult to draw conclusions.
Objective(s): To examine differences in the way CP-led medication review studies are set up. This was accomplished by investigating (1) patient selection criteria, (2) components of the medication review interventions, (3) types of outcomes, and (4) measurement instruments used.
Methods: A systematic literature search of randomized controlled trials of CP-led medication reviews was carried out in PubMed and Cochrane Library. Information on patient selection, intervention components, and outcome measurements was extracted, and frequencies were analyzed. Where possible, outcomes were mapped to the Core Outcome Set (COS) for medication review studies. Finally, a network analysis was conducted to explore the
influence of individual factors on outcome effects.
Results: In total, 30 articles (26 studies) were included. Most articles had a drug class-specific or disease-specific patient selection criterion (n = 19). Half of the articles included patients aged =60 years (n = 15), and in 40% (n = 12/30) patients taking 4 drugs or more. In 24 of 30 articles, a medication review was comprised with additional interventions, such as distribution of educational material and training or follow-up visits. About 40 different outcomes were extracted. Within specific outcomes, the measurement instruments varied, and COS was rarely represented.
Conclusion: The revealed differences in patient selection, intervention delivery, and outcome assessment highlight the need for more standardization in research on CP-led medication reviews. While intervention delivery should be more precisely described to capture potential differences between interventions, outcome assessment should be standardized in terms of outcome selection by application of the COS, and with regard to the selected core outcome measurement instruments to enable comparison of the results.

Contributors

Cathrin J. Vogt, Robert Moecker, Christian O. Jacke, Walter E. Haefeli, Hanna M. Seidling

Publication

Journal: Research in Social and Administrative Pharmacy
Volume: 20
Issue:
Pages: 679 - 688
Year: 2024
DOI: 10.1016/j.sapharm.2024.03.012

Further Study Information

Current Stage: Completed
Date:
Funding source(s): This research was financed by the Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, and did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.


Health Area

Disease Category: Health care of older people

Disease Name: Polypharmacy

Target Population

Age Range: 65 - 100

Sex: Either

Nature of Intervention: Drug

Stakeholders Involved

Study Type

- COS uptake study

Method(s)

- Systematic review

A systematic literature search of randomized controlled trials of CP-led medication reviews was carried out in PubMed and Cochrane Library. Information on patient selection, intervention components, and outcome measurements was extracted, and frequencies were analyzed. Where possible, outcomes were mapped to the Core Outcome Set (COS) for medication review studies. Finally, a network analysis was conducted to explore the
influence of individual factors on outcome effects.